Therasid Bioscience in NASH-Summit

by Jay in Therasid Bioscience April 25, 2018
2nd NASH-Summit maybe finalized very succesfully, because number of the attendee is double compared to 1st meeting. Therasid Bioscience joined this meeting from pre-conference to main conference for the purpose of strong global network in NASH field. More friendly and casual network was made with Gilead, Novartis and Esperion. Intercept pharma and Genfit presented comprehensive talks in the plenary lecture as an initiative of global NASH workspace, we also made networks with these company's top management members, for consulting future clinical development starategy and exchanges of information about clinical trial results including non-invasive biomarker.

Therasid Bioscience